Phase IIIB

Related by string. Phase IIIb * phases . Phases . phase . PHASE . PHASES : Phase III clinical trials . Phase III trials . Phase III clinical . Phase 2b clinical . pivotal Phase III . ongoing Phase 1b . Phase III Clinical Trial / IIIb : ongoing Phase IIIb . IIIB NSCLC . Stage IIIB IV . CAT IIIB . stage IIIB IV . stage IIIb IV * Phase IIIb clinical . Phase IIIb study . Phase IIIB IV . confirmatory Phase IIIb *

Related by context. Frequent words. (Click for all words.) 54 Phase II 53 Phase 53 Phases II 51 Phase III 50 placebo controlled Phase 49 Phase Ib clinical 49 Phase IV 48 phase IIa 47 PA# [002] 47 Pivotal Phase III 47 phase IIb 47 RSD# 46 Pivotal Phase 46 Lu AA# 46 alvimopan 46 Phase 2b study 45 Phase 1a 45 elotuzumab 45 IND submission 45 Phase 1b 45 ATTAIN 45 KRN# 45 AeroLEF 44 eltrombopag 44 Atiprimod 44 Gabapentin GR 44 Pivotal Trial 44 Phase IIb 44 Phase 2b 44 isavuconazole 43 Phase 1b clinical 43 Phase 2b trial 43 preclinical toxicology 43 By Arek Sarkissian 43 Phase IIa clinical 43 confirmatory Phase III 43 methylnaltrexone 42 dose titration 42 Phase Ib 42 pegloticase 42 pivotal Phase 42 GSK# [001] 42 diabetic neuropathic pain 42 MAP# 42 Panzem R 42 Zerenex 42 BEMA Buprenorphine 42 romidepsin 42 Phase IIa trial 42 IIb 42 tapentadol 42 ATL# [001] 42 ATTRACT 42 Phase III Clinical Trial 42 ocrelizumab 42 double blinded placebo 42 nab paclitaxel 42 Phase 2a 42 PRECiSE 42 BY DOUGLAS HANKS 41 celgosivir 41 Phase 2a trial 41 Phase 2b clinical 41 pharmacodynamic effects 41 relapsed refractory multiple myeloma 41 Phase 2a clinical 41 avanafil 41 Pirfenidone 41 NVA# 41 BAY #-# 41 Initiates Phase 41 Ofatumumab 41 Cloretazine R VNP#M 41 Traficet EN 41 BCX# 41 Azedra 41 TELCYTA 40 alogliptin 40 INCB# [002] 40 ASA# 40 EPC# 40 Phase Ia 40 aclidinium 40 MIRCERA 40 Amrubicin 40 Phase IIa 40 pivotal Phase III 40 cutaneous T cell 40 pharmacokinetic studies 40 anticancer compound 40 eculizumab 40 Phase III pivotal 40 ENACT 40 BrachySil 40 phase 2a 40 Metastatic Melanoma 40 KNS # 40 crofelemer 40 eniluracil 40 multicentre 40 Clinical Trial Results

Back to home page